DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-6.74%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.47B
AUM Growth
+$4.47B
(-5.9%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
41.88%
Holding
141
New
13
Increased
10
Reduced
16
Closed
18
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$48.9M |
| 2 |
Gilead Sciences
GILD
|
$45.5M |
| 3 |
Pulmonx
LUNG
|
$33M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$26.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
$26.2M |
Top Sells
| 1 |
APR
Apria, Inc. Common Stock
APR
|
$54M |
| 2 |
Glaukos
GKOS
|
$45.8M |
| 3 |
Protagonist Therapeutics
PTGX
|
$40.1M |
| 4 |
Centene
CNC
|
$37.9M |
| 5 |
Pacira BioSciences
PCRX
|
$35.9M |
Sector Composition
| 1 | Healthcare | 54.47% |
| 2 | Financials | 1.5% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$5.52B
| $269M | 6.01% | 19,341,024 | – | – |
|
2
Viatris
VTRS
$12.3B
| $225M | 5.03% | 20,673,700 -100,300 | -0.5% | -$1.09M |
|
3
AdaptHealth
AHCO
$1.28B
| $187M | 4.18% | 11,650,072 +1,424,627 | +14% | +$22.8M |
|
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $155M | 3.47% | 1,657,800 +279,855 | +20% | +$26.2M |
|
|
CMAX
5
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $122M | 2.72% | 15,861,090 -917,660 | -5% | -$7.05M |
|
|
6
Pulmonx
LUNG
$69.7M
| $91.7M | 2.05% | 3,695,341 +1,328,474 | +56% | +$33M |
|
|
SILK
7
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $88.9M | 1.99% | 2,153,712 +636,531 | +42% | +$26.3M |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $82.3M | 1.84% | 4,891,996 +130,858 | +3% | +$2.2M |
|
9
Mirum Pharmaceuticals
MIRM
$3.71B
| $72.3M | 1.62% | 3,282,912 | – | – |
|
10
Kura Oncology
KURA
$686M
| $71M | 1.59% | 4,416,361 +902,605 | +26% | +$14.5M |
|
11
Organogenesis Holdings
ORGO
$653M
| $64.4M | 1.44% | 8,456,876 | – | – |
|
|
DCPH
12
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $51.7M | 1.16% | 5,580,456 | – | – |
|
|
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $48.9M | 1.09% | +465,000 | New | +$48.9M |
|
|
14
Centene
CNC
$14.3B
| $46.6M | 1.04% | 553,800 -450,000 | -45% | -$37.9M |
|
|
15
Gilead Sciences
GILD
$140B
| $45.5M | 1.02% | +765,489 | New | +$45.5M |
|
16
Molina Healthcare
MOH
$9.8B
| $45M | 1.01% | 134,989 | – | – |
|
|
AERI
17
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $42.7M | 0.96% | 4,695,020 | – | – |
|
18
GeneDx Holdings
WGS
$3.72B
| $42.5M | 0.95% | 13,848,488 -118,336 | -0.8% | -$363K |
|
|
OMIC
19
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $41.7M | 0.93% | 6,612,019 -2,500,000 | -27% | -$15.8M |
|
20
Alphatec Holdings
ATEC
$2.35B
| $41.3M | 0.92% | 3,594,829 | – | – |
|
21
Edgewise Therapeutics
EWTX
$1.51B
| $38.2M | 0.85% | 3,933,137 | – | – |
|
22
Brookdale Senior Living
BKD
$1.83B
| $37.9M | 0.85% | 5,379,000 +1,104,192 | +26% | +$7.78M |
|
23
Cytokinetics
CYTK
$4.23B
| $35.1M | 0.78% | 952,703 +143,703 | +18% | +$5.29M |
|
24
The Oncology Institute
TOI
$318M
| $32.1M | 0.72% | 3,296,107 | – | – |
|
25
Pharvaris
PHVS
$1.39B
| $28.6M | 0.64% | 1,577,078 -4,253 | -0.3% | -$77.1K |
|